Companies · AME
AMETEK
AI-generated · informational only · not investment advice · verify before relying.
Latest analysis
Updated Nov 3, 2026
AMETEK Q3 2026: record sales and orders on 10% organic growth and $5.3B acquisition blitz
AMETEK delivered record third-quarter sales of $2.22 billion, up 17.3% year-over-year, on the back of 10% organic sales growth and a 7% contribution from four acquisitions completed between July and August 2026 (FARO, LKC, First Aviation, Indicor). Orders hit a record $2.65 billion, up 34.7%, with the backlog now at $4.54 billion—a 26.8% increase from year-end 2025. Segment operating margins expanded 130 basis points organically (excluding acquisition dilution and integration costs), and the company's debt-to-capital ratio rose to 36.3% from 17.7% to fund the $5.3 billion acquisition spend year-to-date. The company notes tariff exposure remains a monitoring priority but has not materially impacted nine-month results.
Tone: bullishRevenue
$7.4B
AME 10-K · FY 2025
Employees
22,500
Revenue growth YoY
+6.6%
Founded
1930
Profile
AME 10-K Item 1 · Feb 17, 2026AMETEK is a leading global manufacturer of electronic instruments and electromechanical devices serving process, aerospace, medical, defense, and industrial markets through two operating segments: Electronic Instruments (EIG) and Electromechanical (EMG). The company grows through a combination of operational excellence, strategic acquisitions, new product development, and global market expansion. Its asset-light model generates strong cash flow, which is deployed primarily into value-enhancing acquisitions.
Read filing description ↓ Collapse description ↑
AMETEK, Inc. is incorporated in Delaware and maintains its principal executive offices in Berwyn, Pennsylvania. It is a leading global manufacturer of electronic instruments and electromechanical devices with operations in North America, Europe, Asia and South America. AMETEK's products are marketed and sold worldwide through two operating groups: Electronic Instruments (EIG) and Electromechanical (EMG). EIG is a leader in the design and manufacture of advanced instruments for the process, power and industrial, and aerospace markets. EMG is a differentiated supplier of precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals and electrical interconnects, with end markets including aerospace and defense, medical, automation and other industrial markets. AMETEK is committed to achieving earnings growth through the successful implementation of the AMETEK Growth Model, which integrates four growth strategies: Operational Excellence, Strategic Acquisitions, Global and Market Expansion, and New Product Development, with a focus on cash generation and capital deployment. The goal of the Growth Model is high single digit annual percentage growth in sales and double digit annual percentage growth in earnings per share over the business cycle, strong cash flow generation, and a superior return on total capital. Since the beginning of 2021 through December 31, 2025, AMETEK has completed 15 acquisitions with annualized sales totaling approximately $1.8 billion. In 2025, approximately 27% of sales were from products introduced in the past three years.
Primary products
- process analyzers, emission monitors and spectrometers
- elemental and surface analysis instruments
- level, pressure and temperature sensors and transmitters
- radiation measurement devices
- precision manufacturing systems
- materials- and force-testing instruments
Business segments
End markets
Geographies
“In EIG's markets, AMETEK believes it ranks as a leader in certain analytical measurement and control instruments, and power and industrial markets.” Competitive position, as stated in the filing
Revenue commentary · FY 2025
Net sales for 2025 increased $459.9 million or 6.6% versus 2024, driven by a 4% contribution from acquisitions, 2% organic sales growth, and a 1% favorable foreign currency translation effect.
The rest of AME is for subscribers
Analysis, signals, diligence answers, M&A activity and every quote, each citing the filing it came from.